Cargando…
Long-term treatment with lanthanum carbonate reduces mineral and bone abnormalities in rats with chronic renal failure
Background. Lanthanum carbonate (FOSRENOL(®), Shire Pharmaceuticals) is an effective non-calcium, non-resin phosphate binder for the treatment of hyperphosphataemia in patients with chronic kidney disease (CKD). In this study, we used a rat model of chronic renal failure (CRF) to examine the long-te...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3107768/ https://www.ncbi.nlm.nih.gov/pubmed/21098011 http://dx.doi.org/10.1093/ndt/gfq682 |